The evolving role of radiotherapy in oligometastatic pancreatic cancer: from palliation to disease-modifying multidisciplinary integration. [PDF]
Zhang J +6 more
europepmc +1 more source
Oligometastatic neuroendocrine tumors: characteristics and prognosis. [PDF]
Melhorn P +3 more
europepmc +1 more source
Lymphocyte Kinetics and Outcomes After Comprehensive Involved-Site Radiotherapy for Oligometastases. [PDF]
Patel D +4 more
europepmc +1 more source
Bevacizumab plus iparomlimab/tuvonralimab with hepatic artery infusion chemotherapy followed by stereotactic body radiotherapy in patients with BCLC stage C hepatocellular carcinoma with thrombus and/or extrahepatic oligometastases (BITS-TO-HCC): study protocol of a prospective, single-center, single-arm, phase II study. [PDF]
Liu Y +13 more
europepmc +1 more source
Oligometastatic Prostate Cancer: Clues from an N-of-1. [PDF]
Kirschenbaum A +7 more
europepmc +1 more source
Bibliometric analysis of stereotactic ablative radiotherapy for oligometastases. [PDF]
Di Y, Song Z, Wang Y, Meng L, Li J.
europepmc +1 more source
Phase II Study of Dose-Escalated and Convergent Stereotactic Body Radiotherapy for Liver and Pulmonary Oligometastases from Colorectal Cancer. [PDF]
Nishimura S +5 more
europepmc +1 more source
Single- Versus Multi-Fraction Stereotactic Body Radiotherapy for Primary Lung Cancer and Pulmonary Oligometastases: A Systematic Review and Meta-Analyses. [PDF]
Pillay I, Gee H, Hau E, Ong A, Gebski V.
europepmc +1 more source
Case Report: MR-guided adaptive stereotactic body radiotherapy for splenic metastases: a case series of technical feasibility and early clinical outcomes. [PDF]
Tan D +8 more
europepmc +1 more source
Single-fraction stereotactic radiotherapy for lung malignancies: preliminary results of a mono-institutional experience. [PDF]
Cuccia F +13 more
europepmc +1 more source

